Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Am Soc Nephrol
2013 Jun 01;247:1045-52. doi: 10.1681/ASN.2012080869.
Show Gene links
Show Anatomy links
AqF026 is a pharmacologic agonist of the water channel aquaporin-1.
Yool AJ, Morelle J, Cnops Y, Verbavatz JM, Campbell EM, Beckett EA, Booker GW, Flynn G, Devuyst O.
???displayArticle.abstract???
Aquaporin-1 (AQP1) facilitates the osmotic transport of water across the capillary endothelium, among other cell types, and thereby has a substantial role in ultrafiltration during peritoneal dialysis. At present, pharmacologic agents that enhance AQP1-mediated water transport, which would be expected to increase the efficiency of peritoneal dialysis, are not available. Here, we describe AqF026, an aquaporin agonist that is a chemical derivative of the arylsulfonamide compound furosemide. In the Xenopus laevis oocyte system, extracellular AqF026 potentiated the channel activity of human AQP1 by >20% but had no effect on channel activity of AQP4. We found that the intracellular binding site for AQP1 involves loop D, a region associated with channel gating. In a mouse model of peritoneal dialysis, AqF026 enhanced the osmotic transport of water across the peritoneal membrane but did not affect the osmotic gradient, the transport of small solutes, or the localization and expression of AQP1 on the plasma membrane. Furthermore, AqF026 did not potentiate water transport in Aqp1-null mice, suggesting that indirect mechanisms involving other channels or transporters were unlikely. Last, in a mouse gastric antrum preparation, AqF026 did not affect the Na-K-Cl cotransporter NKCC1. In summary, AqF026 directly and specifically potentiates AQP1-mediated water transport, suggesting that it deserves additional investigation for applications such as peritoneal dialysis or clinical situations associated with defective water handling.
Agre,
Aquaporin water channels (Nobel Lecture).
2004, Pubmed
Agre,
Aquaporin water channels (Nobel Lecture).
2004,
Pubmed Brimble,
Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis.
2006,
Pubmed Campbell,
The activity of human aquaporin 1 as a cGMP-gated cation channel is regulated by tyrosine phosphorylation in the carboxyl-terminal domain.
2012,
Pubmed
,
Xenbase Devuyst,
Aquaporin-1 and endothelial nitric oxide synthase expression in capillary endothelia of human peritoneum.
1998,
Pubmed Devuyst,
The pathophysiology of the peritoneal membrane.
2010,
Pubmed Fu,
The structural basis of water permeation and proton exclusion in aquaporins.
2007,
Pubmed Gao,
Acetazolamide inhibits osmotic water permeability by interaction with aquaporin-1.
2006,
Pubmed
,
Xenbase Huber,
Inhibition of aquaporin 4 by antiepileptic drugs.
2009,
Pubmed
,
Xenbase Kim,
Regulation of pacemaker frequency in the murine gastric antrum.
2002,
Pubmed King,
Defective urinary concentrating ability due to a complete deficiency of aquaporin-1.
2001,
Pubmed Leeson,
The influence of drug-like concepts on decision-making in medicinal chemistry.
2007,
Pubmed Lin,
Phosphodiesterase 4 inhibition attenuates atrial natriuretic peptide-induced vascular hyperpermeability and loss of plasma volume.
2011,
Pubmed Ma,
Severely impaired urinary concentrating ability in transgenic mice lacking aquaporin-1 water channels.
1998,
Pubmed Maurel,
Plant aquaporins: membrane channels with multiple integrated functions.
2008,
Pubmed Migliati,
Inhibition of aquaporin-1 and aquaporin-4 water permeability by a derivative of the loop diuretic bumetanide acting at an internal pore-occluding binding site.
2009,
Pubmed
,
Xenbase Musini,
Blood pressure lowering efficacy of loop diuretics for primary hypertension.
2009,
Pubmed Ni,
Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis.
2006,
Pubmed Ni,
Functional and molecular characterization of a peritoneal dialysis model in the C57BL/6J mouse.
2005,
Pubmed Nielsen,
Distribution of the aquaporin CHIP in secretory and resorptive epithelia and capillary endothelia.
1993,
Pubmed Rippe,
Computer simulations of peritoneal fluid transport in CAPD.
1991,
Pubmed Smit,
Analysis of the prevalence and causes of ultrafiltration failure during long-term peritoneal dialysis: a cross-sectional study.
2004,
Pubmed Stoenoiu,
Corticosteroids induce expression of aquaporin-1 and increase transcellular water transport in rat peritoneum.
2003,
Pubmed Tomita,
Effects of removal of Na(+) and Cl(-) on spontaneous electrical activity, slow wave, in the circular muscle of the guinea-pig gastric antrum.
2000,
Pubmed Törnroth-Horsefield,
Structural mechanism of plant aquaporin gating.
2006,
Pubmed Trott,
AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.
2010,
Pubmed Verkman,
Aquaporins in clinical medicine.
2012,
Pubmed Wouters,
Subtractive hybridization unravels a role for the ion cotransporter NKCC1 in the murine intestinal pacemaker.
2006,
Pubmed Yang,
Lack of aquaporin-4 water transport inhibition by antiepileptics and arylsulfonamides.
2008,
Pubmed Yang,
Reduced osmotic water permeability of the peritoneal barrier in aquaporin-1 knockout mice.
1999,
Pubmed Yool,
Roles for novel pharmacological blockers of aquaporins in the treatment of brain oedema and cancer.
2010,
Pubmed Yool,
Functional domains of aquaporin-1: keys to physiology, and targets for drug discovery.
2007,
Pubmed Yu,
Mechanism of gating and ion conductivity of a possible tetrameric pore in aquaporin-1.
2006,
Pubmed Yukutake,
Mercury chloride decreases the water permeability of aquaporin-4-reconstituted proteoliposomes.
2008,
Pubmed
,
Xenbase Zelenina,
Water permeability of aquaporin-4 is decreased by protein kinase C and dopamine.
2002,
Pubmed Zhu,
A Ca(2+)-activated Cl(-) conductance in interstitial cells of Cajal linked to slow wave currents and pacemaker activity.
2009,
Pubmed
